Sh Pharmaceutical reported CNY2.77B in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Jiangsu Hengrui CNY 2.85B 1.17B Sep/2026
Sh Fosun Pharma CNY 863.03M 301.08M Sep/2026
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Wuxi Apptec CNY 7.44B 390.43M Sep/2026